// App-Quantinova.ai

1600 : Correlation of high body mass index and circulating tumor cell positivity in patients with early-stage breast cancer.

Researchers

Presenter

  • Uta Ortmann

Principal Investigators

  • Wolfgang Janni

  • Ulrich Andergassen

  • Joerg Schreier

  • Frank Spickhoff

  • Thomas Zwingers

  • Brigitte Kathrin Rack

  • Thomas Beck

  • Matthias W. Beckmann

  • Werner Lichtenegger

  • Julia Katharina Neugebauer

  • Jessica Salmen

  • Christian Schindlbeck

  • Andreas Schneeweiss

  • Christoph Scholz

Medical Centers

  • Ludwig Maximilians University Munich, Munich, Germany

  • Staedtisches Klinikum Rosenheim, Rosenheim, Germany

  • National Center for Tumor Diseases DKFZ, Heidelberg, Germany

  • Charite Medical University, Berlin, Germany

  • Frauenklinik Klinikum Traunstein, Traunstein, Germany

  • Heinrich-Heine-Universitat, Dusseldorf, Germany

  • Heinrich Heine University Duesseldorf, Duesseldorf, Germany

  • DRK Kliniken Berlin Kopenick, Berlin, Germany

  • University of Erlangen-Nuernberg, Erlangen, Germany

  • Estimate, Augsburg, Germany

  • St.-Antonius-Hospital Eschweiler, Eschweiler, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Obesity

  • Solid malignancies

Biomarkers

  • Circulating tumor cells

  • Body mass index

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Zoledronic acid

  • Fluorouracil

  • Adrucil injection

  • Gemcitabine

  • Epirubicin

  • Docetaxel

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved